A pharmacokinetically advanced Ashwagandha extract standardized to 35% glycowithanolides. Designed to support stress response, resilience, sleep quality, and recovery at a clinically studied low dose of 120mg.
Key Benefits
Standardized to 35% Glycowithanolides — a highly concentrated and defined bioactive profile
Enhanced Bioavailability — demonstrated superior pharmacokinetic performance compared to conventional extracts
Clinically Studied at 120 mg — low-dose, research-backed precision
